NCT03627689

Molekule for Allergic Rhinitis/Asthma

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 49 (actual)
• Sponsor: Molekule · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Exposure to airborne allergens and pollutants is linked to symptom severity of allergies, asthma and other respiratory problems. In this study an air purifier using photo-electrochemical oxidation technology (PECO) will be used in the home environment of study participants. The investigator will assess the reduction of symptoms from allergic rhinitis/conjunctivitis and asthma.

Detailed description

The purpose of this study is to assess the efficacy of the portable PECO air purifier in reducing symptoms from allergic rhinitis and asthma. Using a randomized, double blinded placebo, controlled trial we will be then able to assess if there are any changes after the use of the PECO air purifier after completing an initial baseline survey \& comparing to the exit survey. This is a double-blind study, which means that neither the participant nor the investigator knows which device is being used until after the trial is over.

Conditions

• Asthma
• Allergic Rhinitis
• Allergic Conjunctivitis

Interventions

Type	Name	Description
OTHER	Active air purifier in respiratory allergies/asthma	Continuous use of air purifier to improve allergies and asthma control
OTHER	Sham air purifier	control arm

Timeline

• Start date: 2018-07-13
• Primary completion: 2019-01-31
• Completion: 2019-01-31
• First posted: 2018-08-13
• Last updated: 2019-02-05

Locations

1 site across 1 country: United States